Racial Disparity in the Use of Atypical Antipsychotic Medications Among Veterans
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study assessed the current state of antipsychotic prescription practices regarding race among veterans receiving care through the Department of Veterans Affairs. METHOD: The authors examined pharmacy records over a 12-month period for all veterans with schizophrenia and antipsychotic prescriptions in fiscal year 1999. They used logistic regression analysis to assess the effect of race on the use of various atypical antipsychotic agents. Analytic models controlled for age, sex, comorbid substance use, bipolar disorder, and other psychosis. RESULTS: The sample of 69,787 veterans with schizophrenia was 61.3% white, 30.1% African American, and 8.5% Hispanic. Among them, 39% had prescriptions for conventional antipsychotics, 37% for atypical antipsychotics, and 23% for both atypical and conventional antipsychotics. Use of any atypical agent during the year was less likely for Hispanic veterans (55%) than for two other groups (both 61%). When examining specific medications in a multivariate model, the authors found that African American and Hispanic veterans were much less likely to receive clozapine than were white veterans. CONCLUSIONS: Overall use of atypical antipsychotics was slightly less common for African American and Hispanic veterans with schizophrenia than for white patients. However, use of clozapine, the first choice for refractory illness and possibly uniquely effective for patients with comorbid substance abuse, did vary greatly by race. This may reflect concern over serious side effects, such as loss of white blood cells and fluctuations of serum glucose levels, or patient preference.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Lehman, A. F., Steinwachs, D. M., & The Co-Investigators of the PORT Project (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033302 · Cited by 910 · cited 2×
“Clozapine is the first choice for the treatment of refractory cases of schizophrenia (24) and is singularly effective in treating patients with comorbid substance use disorders (38, 39).”
Background
Cited by
Coleman, K. J., Stewart, C., Waitzfelder, B. E., Zeber, J. E., Morales, L. S., Ahmed, A. T., Ahmedani, B. K., Beck, A., Copeland, L. A., Cummings, J. R., et al. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500217 · Cited by 129
“Second, the few studies using electronic medical records (EMRs) to examine diagnosis and treatment patterns are from a narrow cross-section of providers and systems, relatively small samples of patients from racial-ethnic minorities, and reflect a large proportion of patients receiving federally subsidized care (Veter…”
BackgroundSelf-citationNational trends in ethnic disparities in mental health care
Blanco, C., Patel, S. R., Liu, L., Jiang, H., Lewis-Fernández, R., Schmidt, A. B., Liebowitz, M. R., & Olfson, M. (2007) · Medical Care · doi:10.1097/mlr.0b013e3180ca95d3 · Cited by 125
Medlock, M., Weissman, A., Wong, S. S., Carlo, A., Zeng, M., Borba, C., Curry, M., & Shtasel, D. (2017) · MedEdPORTAL · doi:10.15766/mep_2374-8265.10618 · Cited by 60
Metadata
- Authors
- Copeland, L. A., Zeber, J. E., Valenstein, M., & Blow, F. C.
- Venue
- American Journal of Psychiatry
- Published
- 2003-10-01
- Volume
- 160
- Issue
- 10
- Pages
- 1817-1822
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2166701818
- Cited by
- 85
- References
- 3
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Racial Disparity in the Use of Atypical Antipsychotic Medications Among Veterans. https://app.cochat.ai/papers/10.1176/appi.ajp.160.10.1817
- The paper
- Copeland, L. A., Zeber, J. E., Valenstein, M., & Blow, F. C. (2003). Racial Disparity in the Use of Atypical Antipsychotic Medications Among Veterans. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.160.10.1817
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.